Table: Sapporo Clinical Lab -2021/22 parent results

Sapporo Clinical Laboratory

13/05/2022 07:30

May 13 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.74           16.37          16.74         8.31    
               (+8.3 pct)      (-0.8 pct)     (-5.6 pct)    (-6.3 pct) 
  Operating        1.46            1.10                                
               (+33.1 pct)     (+20.4 pct)                             
  Recurring        1.57            1.17         940 mln      403 mln   
               (+33.9 pct)     (+24.0 pct)    (-40.0 pct)  (-51.2 pct) 
  Net              1.02          791 mln        632 mln      270 mln   
               (+29.5 pct)     (+57.2 pct)    (-38.3 pct)  (-43.0 pct) 
  EPS          300.67 yen      231.10 yen     188.58 yen    80.67 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T